References
- Redman CW. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet2(7989), 753–756 (1976).
- Cockburn J, Moar VA, Ounsted M et al. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet1(8273), 647–649 (1982).
- Umans JG, Lindheimer MD. Antihypertensive therapy in pregnancy. Curr. Hypertens. Rep.5(3), 392–399 (2001).
- Abalos E, Duley L, Steyn DW et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst. Rev.2, CD002252 (2001).
- Gifford RW, August PA, Cunningham G et al. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am. J. Obstet. Gynecol.183, S1–S22 (2000).
- Pickles CJ, Broughton Pipkin F, Symonds EM. A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Br. J. Obstet. Gynaecol.99(12), 964–968 (1992).
- Blake S, MacDonald D. The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment. Br. J. Obstet. Gynaecol.98(3), 244–248 (1991).
- Von Dadelszen P, Ornstein MP, Bull SB et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet355(9198), 87–92 (2000).
- Khedun SM, Moodley J, Naicker T et al. Drug management of hypertensive disorders of pregnancy. Pharmacol. Ther.74(2), 221–258 (1997).
- No authors listed. National High Blood Pressure Education Program Working Group Report on high blood pressure in pregnancy. Am. J. Obstet. Gynecol.183(1), S1–S22 (2000).
- Dekker G, Sibai BM. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet357(9521), 209–215 (2001).
- Coppage KH, Sibai BM. Treatment of hypertensive complications in pregnancy. Curr. Pharm. Des.11(6), 749–759 (2005).
- Abalos E, Duley L, Steyn D et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst. Rev.1, CD002252 (2007).
- von Dadelszen P, Magee LA. Antihypertensive medications in management of gestational hypertension-preeclampsia. Clin. Obstet. Gynecol.48(2), 441–459 (2005).
- Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ318(7194), 1332–1336 (1999).
- Mancia G, De Backer G, Dominiczak A et al.; Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH), European Society of Cardiology (ESC). 2007 ESH-ESC guidelines for the management of arterial hypertension. J. Hypertens.25(6), 1105–1187 (2007).
- Lydakis C, Lip GYH, Beevers M et al. Atenolol and fetal growth in pregnancies complicated by hypertension. Am. J. Hypertens.12(6), 541–547 (1999).
- The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet359(9321), 1877–1890 (2002).